0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Clinical Observation |

Treatment of a Bowenoid Papulosis of the Penis With Local Applications of Cidofovir in a Patient With Acquired Immunodeficiency Syndrome

Robert Snoeck, MD, PhD; Yves Van Laethem, MD; Erik De Clercq, MD, PhD; Josiane De Maubeuge, MD; Nathan Clumeck, MD, PhD
Arch Intern Med. 2001;161(19):2382-2384. doi:10.1001/archinte.161.19.2382.
Text Size: A A A
Published online

Extract

We report a case of bowenoid papulosis in a patient with acquired immunodeficiency syndrome that was successfully treated with local applications of cidofovir in Beeler base. This treatment should be confirmed as a valuable nonagressive therapy for such potentially invasive viral-induced cell proliferation.

Patterson  JWKao  GFGraham  JHHelwig  WB Bowenoid papulosis: a clinicopathologic study with ultrastructural observations. Cancer. 1986;57823- 836
Link to Article[[XSLOpenURL/10.1002/(ISSN)1097-0142]]
Su  CKShipley  WU Bowenoid papulosis: a benign lesion of the shaft of the penis misdiagnosed as squamous carcinoma. J Urol. 1997;1571361- 1362
Link to Article[[XSLOpenURL/10.1016/S0022-5347(01)64981-4]]
Bhojwani  ABiyani  CSNicol  APowell  CS Bowenoid papulosis of the penis. Br J Urol. 1997;80508
Link to Article[[XSLOpenURL/10.1046/j.1464-410X.1997.00389.x]]
De Clercq  E Therapeutic potential of cidofovir (HPMPC, Vistide) for the treatment of DNA virus (i.e. herpes-, papova-, pox- and adenovirus) infections. Verh K Acad Geneeskd Belg. 1996;5819- 49
Snoeck  RNoel  J-CMuller  CDe Clercq  EBossens  M Cidofovir, a new approach for the treatment of cervix intraepithelial neoplasia grade III (CIN III). J Med Virol. 2000;60205- 209
Link to Article[[XSLOpenURL/10.1002/(ISSN)1096-9071]]
Snoeck  RVan Ranst  MAndrei  G  et al.  Treatment of anogenital papillomavirus infections with an acyclic nucleoside phosphonate analogue. N Engl J Med. 1995;333943- 944
Link to Article[[XSLOpenURL/10.1056/NEJM199510053331418]]
Snoeck  RBossens  MParent  D  et al.  A double-blind placebo-controlled study of cidofovir gel for human papillomavirus (HPV)-associated genital warts [abstract]. Antiviral Res. 1998;37A47
Link to Article[[XSLOpenURL/10.1016/S0166-3542(97)00056-9]]
Figures in this Article

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

First Page Preview

View Large
First page PDF preview

Figures

Place holder to copy figure label and caption
Figure 1.

Time line of treatment. HIV indicates human immunodeficiency virus.

Graphic Jump Location
Place holder to copy figure label and caption
Figure 2.

Lesion before treatment.

Graphic Jump Location
Place holder to copy figure label and caption
Figure 3.

Lesion after first application.

Graphic Jump Location
Place holder to copy figure label and caption
Figure 4.

Lesion 2 months after initiation of treatment.

Graphic Jump Location

Tables

References

Correspondence

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Web of Science® Times Cited: 13

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections
PubMed Articles
Jobs
JAMAevidence.com
brightcove.createExperiences();